Aeolus Announces Fiscal Year 2013 Financial Results
23 déc. 2013 08h00 HE
|
Aeolus Pharmaceuticals
MISSION VIEJO, CA--(Marketwired - Dec 23, 2013) - Aeolus Pharmaceuticals, Inc. (OTCQB: AOLS), a biotechnology company developing compounds to protect against radiological and chemical threats with...
Aeolus Files Application for New Patent on AEOL 10150
05 déc. 2013 11h14 HE
|
Aeolus Pharmaceuticals
MISSION VIEJO, CA--(Marketwired - Dec 5, 2013) - Aeolus Pharmaceuticals, Inc. (OTCQB: AOLS)
Filing covers synthesis, formulation and pharmaceutical composition
...
Aeolus' AEOl 10150 Significantly Improves Survival and Protects Lungs in Mice Exposed to Lethal Radiation
29 oct. 2013 08h00 HE
|
Aeolus Pharmaceuticals
MISSION VIEJO, CA--(Marketwired - Oct 29, 2013) - Aeolus Pharmaceuticals, Inc. (OTCQB: AOLS)
Optimal dose of AEOL 10150 improved survival by four times over untreated...
BARDA Exercises $6.0MM in Additional Contract Funding for Development of AEOL-10150 as Treatment for Acute Radiation Syndrome
17 sept. 2013 13h30 HE
|
Aeolus Pharmaceuticals
MISSION VIEJO, CA--(Marketwired - Sep 17, 2013) - Aeolus Pharmaceuticals, Inc. (OTCQB: AOLS)
BARDA exercise options valued at $6.0 million effective September 16, 2013...
Aeolus' AEOL 10150 Subject of $4.3 Million US Government Award for Protection Against Nerve Agents; Data Shows Drug Significantly Improves Survival in Animals Following Exposure to Pilocarpine, a Nerve Agent Surrogate for Soman and Sarin Gas
11 sept. 2013 12h20 HE
|
Aeolus Pharmaceuticals
MISSION VIEJO, CA--(Marketwired - Sep 11, 2013) - Aeolus Pharmaceuticals, Inc. (OTCQB: AOLS)
National Institutes of Health - National Institute of Neurological...
Aeolus Announces Third Quarter Fiscal Year 2013 Financial Results
14 août 2013 16h30 HE
|
Aeolus Pharmaceuticals
MISSION VIEJO, CA--(Marketwired - Aug 14, 2013) - Aeolus Pharmaceuticals, Inc. (OTCQB: AOLS), a biotechnology company developing compounds to protect against radiological and chemical threats with...
Aeolus' AEOL 10150 Significantly Improves Survival From Nitrogen Mustard Exposure to Skin in Animals
02 juil. 2013 08h00 HE
|
Aeolus Pharmaceuticals
MISSION VIEJO, CA--(Marketwired - Jul 2, 2013) - Aeolus Pharmaceuticals (OTCQB: AOLS)
Data presented at 6th Annual NIH CounterACT Network Research Symposium
...
Aeolus' AEOL 10150 Significantly Improves Survival in Animals Exposed to Mustard Gas
26 juin 2013 14h02 HE
|
Aeolus Pharmaceuticals
MISSION VIEJO, CA--(Marketwired - Jun 26, 2013) - Aeolus Pharmaceuticals, Inc. (OTCQB: AOLS)
Data presented at 7th Annual NIH CounterACT Network Research...
Aeolus Strengthens Board of Directors With Oncology, Government Contracting and Financial Industry Veterans
17 mai 2013 14h19 HE
|
Aeolus Pharmaceuticals
MISSION VIEJO, CA--(Marketwired - May 17, 2013) - Aeolus Pharmaceuticals, Inc. (OTCQB: AOLS), a biotechnology company leveraging significant government funding to develop a platform of novel...
Aeolus Pharmaceuticals Announces Second Quarter Fiscal Year 2013 Financial Results
15 mai 2013 14h38 HE
|
Aeolus Pharmaceuticals
MISSION VIEJO, CA--(Marketwired - May 15, 2013) - Aeolus Pharmaceuticals, Inc. (OTCQB: AOLS), a biotechnology company leveraging significant government funding to develop a platform of novel...